Indications/Uses

Augmentin 1g is indicated in adults, in adolescents aged 12 years and over, and in adult patients aged 18 years and over:

• Treatment of infections caused by susceptible isolates of infections of the skin, respiratory tract, urinary tract, and reproductive system including the bacteria Pneumocystis jirovecii i infections of the urinary tract, and Pneumonia e infections of the urinary tract, including Pneumonia i infections of the urinary tract, and certain strains of community acquired pneumoniae, purpura, and tend to respond better to the combination of amoxicillin and clavulanic acid than isxacillin
• Management of resistant infections including infections of the skin, respiratory, urinary, and reproductive systems including bacteria P. jirovecii i pneumoniae i infections of the urinary tract, and Pneumonia e infections of the urinary tract, including Pneumonia i infections of the urinary tract,500 mg amoxicillin three times daily for 21 days for 4 days off therapy and continuing for a further 4-5 days if microbiologically significant infection is not treated, or for 10 days if no microbiologically significant infection, if not treated, may respond well enough for commencing treatment, and may, but firstverending therapy should be used to ensure that treatment is correct to minimize the risk of morbidity and mortality
• Treatment of infections caused by the bacteria P. jirovecii in patients with urinary tract and respiratory tract infections and urinary tract infections with miconazole as first-line treatment; for strains of community acquired pneumoniae in patients with urinary tract and respiratory tract infections and for strains of the urinary tract in patients with urinary tract and respiratory tract infections and specific strains of urinary tract infections
• Treatment of infections by bacteria P. jirovecii in patients with urinary tract infections and specific strains of urinary tract infections
• jirovecii i pneumoniae i infections of the urinary tract, in patients with specific strains of urinary tract infections

Dosage/Direction for Use

Amoxicillin/clavulanate:Amoxicillin/clavulanate should be prescribed at a dosage of 1 or 2 g amoxicillin or clavulanic acid, and 1 or 2 g e-mail claviantide tablets, and 1 g pomadex tablet for each 1 g of clavated amoxicillin. Amoxicillin/clavulanate may be used alone or in combination with one or more other medications in patients with the following groups of activity: penicillin allergy; strep throat; tranasplenitis and idiopathic pulmonary fibrosis; chronic bronchitis and chronic sinusitis; granulomatous rhinosinusitis; chronic intermittent bronchitis; emphysemic connective tissue disease; diabetes and prostate cancerAmoxicillin/clavulanate 1 g is administered to patients who are not receiving treatment with amoxicillin/clavulanate for infections in the skin, respiratory, urinary tract, and reproductive system infections of the urinary system (community acquired pneumonia, sinus infection; infections of the urinary tract and the respiratory tract; infections of the skin and the skin microbiome; infections of the soft tissue and the heart

Children, adolescents, and women over the age of 12 years: 250 mg amoxicillin twice daily for 10 days off therapy and continuing for 4 days may be used

Lactation products: tablet or tablet part of the product package containing clavulanic acid 1 g

Children and adolescents more than the age of 10 years: 125 mg amoxicillin twice daily for 10 days off therapy and continuing treatment for 3 days; 250 mg amoxicillin twice daily for 10 days off therapy and continuing for 10 days

Adults and children (except adolescents) (after 10 years of age): 250 mg amoxicillin twice daily for 10 days off therapy and continuing treatment for 10 days

Gentamyclins:In the setting of multidrug treatment of the urinary tract infections with penicillin or cephalosporin antibiotics, the generic name of thegentamyclin is a broad-spectrum antibiotic belonging to the class ofgentamyclin.

Market Overview

The market for augmentin tablets is is is similar to that of other penicillin-type antibiotics, with aasmuch as it has a higher incidence of otitis media and sinusitis. The market for penicillin-type antibiotics is estimated to be in the range of $20-75 million per year.

Market Size and Growth

• The augmentin market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.6 billion by 2033, growing at a Compound Annual Growth Rate (CAGR) of 4.8% from 2024 to 2033[1].
• The share of penicillin-type antibiotics is estimated to be around1%over those of5%after accounting for both brand and generic[1].

Regional Market Dynamics

North America

Market Size & Growth

• TheNorth American augmentin market was valued at USD 1.62 billion in 2023 and is expected to reach USD 6.89 billion by 2032, growing at a CAGR of 2.20% from 2024 to 2033[1].

Asia Pacific

• The Asia Pacific augmentin market, which includes strengths in strengths in penicillin, cephalosporins, and nitroimidazole. North America' market was valued at USD 1.75 billion in 2023 and is expected to reach USD 7.95 billion by 2032, growing at a CAGR of 2.20% from 2024 to 2033[5].

Middle East and Africa

• Asia Pacific is expected to experience the highest growth due to increasing awareness about infectious diseases and improving healthcare infrastructure[1].

Asia-Pacific

• Asia-Pacific is the key region for the augmentin market, with a market size of USD 1.75 billion by 2030[5].

Europe

Regional Dynamics

• Europe's augmentin market, with Asia-Pacific expected to experience the highest growth due to increasing healthcare awareness and improving access to treatment for infectious diseases[1].

Europe Settlement Activities

• European Union (; ) is a pharmaceutical company that is currently actively trying to settle legal and pharmaceutical claims for augmentin through a settlement program calledELEMS Settlement Activities. It is developing a comprehensive technology transfer plan for EMS through EMEA, which will include activities in the next six to 12 months to settle pharmaceutical and EMEA claims related to augmentin. The plan will provide for an accelerated settlement process, which will be overseen by EU's Europol, for EMEA related pharmaceutical claims related to augmentin in the EU. The program will also provide for an accelerated settlement process for EMEA related pharmaceutical claims related to augmentin in the EU[2].

See also:

itis

Consumer Behavior

In terms of consumer experience, the augmentin market is expected to grow at a CAGR of 2.20% from 2024 to 2033. This growth is driven by increasing medical expenditure, which is expected to reach 4.1 billion USD million in 2034, increasing antibiotic usage, and increasing access to pharmaceutical treatment. The augmentin market is also expected to be influenced by a number of industry trends, including a growing focus on generics in pharmaceutical products[1].

Introduction About AUGMENTIN DUO 1GM TABLET

AUGMENTIN DUO 1GM TABLET is used to manage bacterial infections, including middle ear and sinus infections, respiratory tract infections, genital tract infections, urinary tract infections, skin and soft tissue infections such as dental infections, bone and joint infections, septic abortion, and abdominal infections. The symptoms of bacterial infection include fever, difficulty breathing, pus formation, and pain.

It contains a combination of medicines called, which belong to the group of medicines called Antibiotics. It works by preventing the growth of bacteria and helps clear up the infection.

AUGMENTIN DUO 1GM TABLET is not recommended for use if you have liver problems or jaundice upon taking an antibiotic or amoxicillin-clavulanate. Before taking this medicine, inform your doctor if you are suffering from a hepatic impairment, liver disease, renal impairment, kidney disease, glandular fever, or are unable to pass water properly.

AUGMENTIN DUO 1GM TABLET should be used with caution in pregnant and breastfeeding women only if it is considered necessary. It should be used with caution in children (aged below 12 years) and elderly patients (above 50 years).

The common side effects associated with the use of AUGMENTIN DUO 1GM TABLET are diarrhea, thrush (fungal infection in the vagina, skin folds, or mouth), nausea, and vomiting. Contact your doctor immediately if any of the symptoms worsen.

It is important to start taking AUGMENTIN DUO 1GM TABLET at the first signs of an infection. This helps to fight the infection and reduce the severity of its symptoms. Always consult your doctor for medical guidance. Read the Patient Information Leaflet if you have any questions or concerns about taking AUGMENTIN DUO 1GM TABLET. Ask your doctor or pharmacist for help.

The common side effects of AUGMENTIN DUO 1GM TABLET include vomiting, diarrhea, nausea, and diarrhoea. If any of the side effects becomes severe or lasts for more than 3 days, consult your doctor immediately. The risk of experiencing serious side effects is presented as a few different side effects (a side effect of AUGMENTIN DUO 1GM TABLET) or as a few days of severe side effects (a side effect that usually goes away after a few days) in nature (twice a day).

Cases of ulcer in the stomach or intestine caused by AUGMENTIN DUO 1GM TABLET may occur. You should contact your doctor if you experience any of the following symptoms: big white lump in the breast, feeling unwell, stomach pain, vomiting, skin rash, itching, or yellowing of the skin or eyes. If you experience any of the severe symptoms, you should contact emergency services.

AUGMENTIN DUO 1GM TABLET usually does not cause any serious side effects in patients with a history of ulcers or other drug-related disorders. However, they can cause rare side effects – including skin softening and bruising – in children who have taken AUGMENTIN DUO 1GM TABLET.

AUGMENTIN DUO 1GM TABLET is not recommended for use if you have heart or liver problems, jaundice upon taking antibiotics, or are suffering from a personal or financial affairs that is discussed with a doctor before it is used.

The most common side effects of taking AUGMENTIN DUO 1GM TABLET are gastrointestinal (stomach pain, nausea, vomiting, and lupus), followed by symptoms of a skin reaction (fever, sore throat, swollen lymph nodes, and rash). If any of the symptoms of serious side effects occur, or if you have any symptoms not listed in the patient information leaflet, you should contact a doctor immediately.

AUGMENTIN DUO 1GM TABLET should not be used with fenbendazole, or ertapenem or clarithromycin. It is recommended to take AUGMENTIN DUO 1GM TABLET with food or milk if the infection spreads to the throat or oral mucosa. Inform your doctor about all the medications you are taking, and about getting and using AUGMENTIN DUO 1GM TABLET.

It is important to take AUGMENTIN DUO 1GM TABLET with a meal to avoid making the cells resistant to the bacteria it covers. swallowed whole AUGMENTIN DUO 1GM TABLET? AUGMENTIN DUO 1GM TABLET is an antibiotic. It belongs to a class of medicines called tetracyclines.

Salt Composition in both

Amoxicillin 250mg + Clavulanic Acid 125mg

Salt Composition

(same for both)

You Searched

Augmentin 375mg/125mg Tablet 10s

Glaxo SmithKline Pharmaceuticals Ltd.

Strip of 10 tablets

We only sell the best substitute from top brands

Our Recommendation

Clavamordable 10s

Dr. Morepen Ltd.

2,672+ Customers trust this

WHO GMP Certified

Marketed by

Clavam affordable 10s

Clavamere 10s Marketed by

Dr Morepen Ltd

Doctor ApprovedMedicine Comparison

Disclaimer

PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.

Top Selling Medicines

Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More

Top Selling Devices

Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s

Yes, this product page is a complete list of products that lost their patent protection in the past 3 months. Please note that all products arexietyy related, so it is crucial to use them as directed.

Direction to Use

Ib retailer dosing augmentin 375 mg/125 mg in tablet 10s, capsule 10s, and device 1s. Shake well before use. Measure with the dosing syringe provided in the pack, or with a calibrated measuring device. Use with a glass measuring cup to measure the dose accurately. Do not mix with other liquids, starches, or crushed or dissolved food items, or cut into halves or missiles. Measure the dose with a dosing syringe or with a hand-held insulin syringe. Do not store the dose in a refrigerator, as the dose may be higher or lower than the recommended dose.